Practice Mobile Menu Trigger Overview Experience Team Insights Subscribe to insights March 14, 2024 Client Update European Parliament approves AI Act On March 13, the European Parliament passed a draft of the Artificial Intelligence Act. The AI Act includes requirements f... March 7, 2024 Articles & Books Artificial intelligence in drug development Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial in... March 6, 2024 Webinar The AI revolution in drug development – Key legal considerations Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this ... February 15, 2024 Articles & Books IP financing deals gain traction for companies seeking liquidity Davis Polk partner and IP, Tech & Commercial Transactions practice head Frank Azzopardi authored “IP financing deals gai... February 13, 2024 Client Update U.S. Patent Office issues guidance for AI-assisted inventions On February 12, 2024, the United States Patent and Trademark Office issued inventorship guidance for AI-assisted invention... January 23, 2024 Client Update Revised 2024 jurisdictional thresholds and filing fees under the HSR Act The Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds and filing fee amoun... November 29, 2023 Client Update Three steps for safeguarding trade secrets in the world of generative AI Generative artificial intelligence (generative AI) tools pose new risks to a company’s trade secrets. This client update... October 25, 2023 Articles & Books Intellectual Property 2023: United States Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi and partner Matthew Bacal authored the Unit... October 16, 2023 Articles & Books The growing popularity and complexity of IP financing transactions in the USA Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi authored “The growing popularity and comp... October 13, 2023 Articles & Books Strategic considerations in life sciences partnering Davis Polk partner David Bauer and counsel Samantha Lefland authored “Strategic considerations in life sciences partneri... Load More
March 14, 2024 Client Update European Parliament approves AI Act On March 13, the European Parliament passed a draft of the Artificial Intelligence Act. The AI Act includes requirements f...
March 7, 2024 Articles & Books Artificial intelligence in drug development Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial in...
March 6, 2024 Webinar The AI revolution in drug development – Key legal considerations Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this ...
February 15, 2024 Articles & Books IP financing deals gain traction for companies seeking liquidity Davis Polk partner and IP, Tech & Commercial Transactions practice head Frank Azzopardi authored “IP financing deals gai...
February 13, 2024 Client Update U.S. Patent Office issues guidance for AI-assisted inventions On February 12, 2024, the United States Patent and Trademark Office issued inventorship guidance for AI-assisted invention...
January 23, 2024 Client Update Revised 2024 jurisdictional thresholds and filing fees under the HSR Act The Federal Trade Commission (FTC) announced revised Hart-Scott-Rodino Act (HSR) reporting thresholds and filing fee amoun...
November 29, 2023 Client Update Three steps for safeguarding trade secrets in the world of generative AI Generative artificial intelligence (generative AI) tools pose new risks to a company’s trade secrets. This client update...
October 25, 2023 Articles & Books Intellectual Property 2023: United States Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi and partner Matthew Bacal authored the Unit...
October 16, 2023 Articles & Books The growing popularity and complexity of IP financing transactions in the USA Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi authored “The growing popularity and comp...
October 13, 2023 Articles & Books Strategic considerations in life sciences partnering Davis Polk partner David Bauer and counsel Samantha Lefland authored “Strategic considerations in life sciences partneri...